An alternative approach to relying upon FcγR to crosslink TNFR antibody domains is to pair a combination of TNFR specific antibody domain with a tumor antigen or immune checkpoint specific antibody binding domain, thereby creating a bispecific antibody (bsAb). This evidence concerns the gene FCGR2A and neoplasm.